Day One Biopharmaceuticals Target Price

Day One Biopharmaceuticals target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$21.53

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-03-10	H.C. WainwrightAndrew Maldonado	$21.5	0.1% downside
2025-11-05	Piper Sandler	$26	20.8% upside
2024-08-01	Bank of America SecuritiesAlec Stranahan	$24	11.5% upside
2024-05-07	H.C. WainwrightAndrew Maldonado	$40	85.8% upside
2023-01-08	Piper SandlerJoseph Catanzaro	$45	109% upside
2022-12-15	H.C. Wainwright	$35	62.6% upside
2022-12-14	Needham	$40	85.8% upside
2022-12-05	Goldman Sachs	$45	109% upside
2022-06-20	Piper SandlerJoseph Catanzaro	$40	85.8% upside

Day One Biopharmaceuticals (DAWN) FAQ

Stockcircle tracks target price for Day One Biopharmaceuticals (DAWN), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Day One Biopharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main DAWN overview so you can move from this figure to the surrounding analysis quickly.